A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2002
10/30/2002	CN1377260A Methods and compounds for inhibiting amyloid deposits
10/30/2002	CN1377259A ACE-2 inhibiting compounds and methods of use thereof
10/30/2002	CN1377257A Hybrid matrices and hybrid matrix mixtures
10/30/2002	CN1377238A Composition comprising casein protein and whey protein
10/30/2002	CN1377235A Nutritional compositions which contain non-digestible polysaccharides and use thereof to reduce transport through tight junctions
10/30/2002	CN1376735A Antibiotics-polymer composition
10/30/2002	CN1376677A [2-[5-(2-chloropyridineoxy)]methyl] azacyclobutane polypeptide derivative and its application
10/30/2002	CN1376667A Medical compound with antalgic, inflammation relieving and thrombocyte decoagulating actions
10/30/2002	CN1376664A Propynyl or diene diaryl compounds
10/30/2002	CN1376518A Stable lactase composition
10/30/2002	CN1376507A Medicine for treating beriberi and its preparing process
10/30/2002	CN1376487A Detoxicating and skin-growing ointment for treating burn
10/30/2002	CN1376486A Detoxicating and skin-growing powder for treating burn
10/30/2002	CN1376485A Spray for preventing and treating cold
10/30/2002	CN1376475A Medicine for threating rheumatism, rheumatoid disease, lumbar intervertebral disk protrusion, hyperosteogeny and ischias and its preparing process
10/30/2002	CN1376474A Bone-setting pill 'Jiegudan'
10/30/2002	CN1376469A Slow release antibiotics preparation of bioactive substance
10/30/2002	CN1376468A Freeze dried hydroxy camptothecin powder for injection and its preparing process
10/30/2002	CN1376467A Veterinary medicine containing oxfendazole
10/30/2002	CN1376466A Solution-type oral liquid or injection containing triclabendazole
10/30/2002	CN1376465A Method and apparatus for releasing L-ascorbic acid to derma cortex
10/30/2002	CN1376464A Method for treating cancer with curcumin plus catechin
10/30/2002	CN1376463A Inclusion compound of disulfiram as eye drops and its preparing process
10/30/2002	CN1376462A Prescription of tetracaine hydrochloride solution as mucose anesthetic
10/30/2002	CN1376459A Preparation method for antibiotics composition
10/30/2002	CN1093536C 5-lipoxygenase inhibitor
10/30/2002	CN1093535C Imiazole derivative
10/30/2002	CN1093423C Novel brain endotheliai cell protein and methods for its use
10/30/2002	CN1093421C Process for preparing snuff to treat hepatitis B
10/30/2002	CN1093420C Process for preparing snuff to treat hepatitis A
10/30/2002	CN1093419C Sobering-up tea
10/30/2002	CN1093409C Fracture treating plaster
10/30/2002	CN1093403C Double regulation nutrient health-care product and its preparation method
10/30/2002	CN1093402C Gastritis treating tablet
10/30/2002	CN1093401C Active oxygen, free radical scavenger
10/30/2002	CN1093400C Oral preparation with dimethoate detoxicating
10/30/2002	CN1093399C Small particle liposome aerosols for delivery of anti-cancer drugs
10/30/2002	CA2383469A1 Treatment of t-cell mediated diseases
10/29/2002	US6472563 Recrystallization from aqueous isopropyl alcohol; high purity; thermodynamically stable
10/29/2002	US6472562 N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
10/29/2002	US6472534 Treating tetrahydrofuran derivativ with an oxophilic electrophilic reagent in a manner that is effective to provide the oxazoline compound
10/29/2002	US6472531 Single reaction vessel acylation and deetherification production of crystalline, high purity chemical intermediates for such as pharmaceuticals
10/29/2002	US6472529 Viricides
10/29/2002	US6472526 Shows an inhibitory activity against farnesyl transferase or pharmaceutically acceptable salts or isomers thereof, in pharmaceutical composition and intermediates
10/29/2002	US6472521 Oligonucleotides for the inhibition of human eg5 expression
10/29/2002	US6472507 Carrier based drug delivery system
10/29/2002	US6472506 Polysaccharide-peptide-conjugates
10/29/2002	US6472438 Active topical skin protectants containing S-330
10/29/2002	US6472437 Barrier cream and an active moiety for protecting warfighters and civilians against all types of harmful chemicals, specifically chemical warfare agents (cwas). the topical skin protectant offers a barrier property and an active moiety for
10/29/2002	US6472436 Blocking amyloid protein toxicity in cells using polycylic compounds. also provided are novel methods of decreasing amyloid protein production in cells and methods of inhibiting cell death. invention methods can be used to prevent and treat
10/29/2002	US6472435 Antitumor antiproliferation agent formed by amidation of carboxy acid with aromatic amine compound
10/29/2002	US6472434 Vasoactive agent is administered to the vagina, vulvar area or urethra of the individual undergoing treatment. suitable vasoactive agents are vasodilators, including naturally occurring prostaglandins, synthetic prostaglandin derivatives,
10/29/2002	US6472433 Administering in an animal a dose of atleast 2.5 milligrams of an enantimerically pure r-nonsteroidal anti-inflammatory drugs per kilogram of the animal's body weight for the treatment of inflammation
10/29/2002	US6472432 Treatment of rosacea using lipoic acid
10/29/2002	US6472431 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
10/29/2002	US6472427 Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl)amino]methyl]amino]benzonitrile
10/29/2002	US6472426 Anti- neoplastic, anti-diarrheal, anti-peristaltic, gastro-intestinal anti-spasmodic, anti-viral, anti-retroviral, anti-psoriasis and insecticidal compositions
10/29/2002	US6472423 Pharmaceutical composition
10/29/2002	US6472422 Treating drug addiction
10/29/2002	US6472421 Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an HMG CoA reductase inhibitor
10/29/2002	US6472420 Method for treating a patient with neoplasia by treatment with a paclitaxel derivative
10/29/2002	US6472418 Non-peptide NK1 receptors antagonists
10/29/2002	US6472415 Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes
10/29/2002	US6472413 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
10/29/2002	US6472412 Compounds as PDE IV and TNF inhibitors
10/29/2002	US6472411 Advanced glycation end-product intermediaries and post-amadori inhibition
10/29/2002	US6472407 α and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/29/2002	US6472406 Sulfonamidomethyl phosphonate inhibitors of beta-lactamase
10/29/2002	US6472405 Glycoprotein IIB/IIIA antagonists
10/29/2002	US6472404 HIV protease inhibitors
10/29/2002	US6472403 αV integrin receptor antagonists
10/29/2002	US6472401 Administering an antiallergen of loratadine or metabolite of loratadine, desloratadine; migraines, stroke, orthostatic hypotension, gastrointestinal stasis, nausea, dizziness and jet lag; also psychological disorders; 5-ht7 receptors
10/29/2002	US6472400 Advanced gylcation end-product intermediaries and post-Amadori inhibition
10/29/2002	US6472399 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
10/29/2002	US6472398 Spiropiperidine derivatives as melanocortin receptor agonists
10/29/2002	US6472396 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds
10/29/2002	US6472395 Agent for use in transplantation
10/29/2002	US6472394 MCH antagonists and their use in the treatment of obesity
10/29/2002	US6472393 Serine protease inhibitors
10/29/2002	US6472392 Triazole compounds and the use thereof as dopamine-D3 -ligands
10/29/2002	US6472391 Nitrogen-containing heterocyclic compounds
10/29/2002	US6472390 Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
10/29/2002	US6472388 Psychotherapeutic agents.
10/29/2002	US6472385 Compositions and methods to enhance cancer chemotherapy in p53 defective tumors
10/29/2002	US6472384 Antimicrobial compounds
10/29/2002	US6472383 Pharmaceutical formulations
10/29/2002	US6472382 4-halogenated steroids, their preparation process and intermediates, their use as medicaments and the pharmaceutical compositions containing them
10/29/2002	US6472381 Method of treating psoriasis
10/29/2002	US6472380 Glucosamine sulfate calcium chloride composition and processes for the preparation of glucosamine sulfate metal chlorides
10/29/2002	US6472379 Angiogenesis inhibition
10/29/2002	US6472378 Compositions and methods for treatment of mitochondrial diseases
10/29/2002	US6472376 Gene therapy
10/29/2002	US6472372 6-O-Carbamoyl ketolide antibacterials
10/29/2002	US6472371 Macrolides
10/29/2002	US6472370 Anticonvulsant derivatives useful in treating post traumatic stress disorder
10/29/2002	US6472212 Methods and compositions for genetically modifying primate bone marrow cells
10/29/2002	US6472183 Immunity against Actinobacillus pleuropneumoniae's RTX toxins APX
10/29/2002	US6472172 DNA encoding a novel human inhibitor-of-apoptosis protein
10/29/2002	US6472158 Ustilipides, method for the production and the use thereof
10/29/2002	US6472157 Methods for detection of promoter polymorphism in a UGT gene promoter

1 ... 5667 5668 5669 5670 5671 5672 5673 5674 5675 5676 5677 5678 5679 5680 5681 5682 5683 5684 5685 5686 5687 ... 7860